Q4 2020 13F Holders as of 31 Dec 2020
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
108,294,335
-
Total 13F shares
-
61,952,909
-
Share change
-
+6,714,279
-
Total reported value
-
$3,397,683,589
-
Put/Call ratio
-
159%
-
Price per share
-
$54.84
-
Number of holders
-
172
-
Value change
-
+$431,615,785
-
Number of buys
-
101
-
Number of sells
-
55
Institutional Holders of ROCKET PHARMACEUTICALS, INC. - Common Stock (RCKT) as of Q4 2020
As of 31 Dec 2020,
ROCKET PHARMACEUTICALS, INC. - Common Stock (RCKT) was held by
172 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
61,952,909 shares.
The largest 10 holders included
RTW INVESTMENTS, LP, PRICE T ROWE ASSOCIATES INC /MD/, PERCEPTIVE ADVISORS LLC, BlackRock Inc., TANG CAPITAL MANAGEMENT LLC, WELLINGTON MANAGEMENT GROUP LLP, RA CAPITAL MANAGEMENT, L.P., VANGUARD GROUP INC, WESTFIELD CAPITAL MANAGEMENT CO LP, and LORD, ABBETT & CO. LLC.
This page lists
172
institutional shareholders reporting positions in this security
for the Q4 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.